Home
Kieran Lamb's Library tagged → View Popular
Women denied cancer drug that could extend life - The Guardian 21st October 2009
"The National Institute for Health and Clinical Excellence proposes to reject a breast cancer drug despite its own rule changes on end-of-life treatments"
The thorny politics of NHS drug approval - The Guardian 21st October 2009
"The National Institute for Health and Clinical Excellence (Nice) is admired by governments abroad but regularly provokes an outcry in the UK. It was devised to do a job no health minister wants to do – to decide which new medicines are worth having in the NHS and which are too expensive.
The drug companies have been understandably hostile from the outset. More difficult for Nice has been the fury of patients' groups, which have sometimes gone into battle on the manufacturers' behalf."
Cancer drugs case study: 'I thought I had a year at most … the difference is huge' - The Guardian 21st October 2009
"Jo Waters, 55, was diagnosed with breast cancer in 2002.
"I had a mastectomy, chemotherapy and radiotherapy," she said. Then she had six cycles of Herceptin. It appeared to work. "I had two years of remission."
NHS watchdog refuses to sanction life-extending cancer drug - The Times 22nd October 2009
"A drug that can extend the life of women with advanced breast cancer has been turned down for use in the NHS by the cost-effectiveness watchdog.
The National Institute for Health and Clinical Excellence (NICE) said it plans to block use of Tykerb (lapatinib) in the Health Service after a second review. The decision comes despite rule changes brought in to let people at the end of their lives have the chance of new and often expensive treatments. "
Thousands of breast cancer sufferers to be denied life extending drug - Daily Telegraph 21st October 2009
"Breast cancer sufferers at the end of their lives should be denied a new drug that could give them three extra months, the NHS rationing body has recommended. "
Breast cancer sufferers will be denied life-extending drug championed by Jane Tomlinson - Daily Mail 21st October 2009
"Thousands of patients with advanced breast cancer are to be denied a 'last chance' drug on the NHS.
The Government's rationing body said lapatinib is too expensive even though its makers will provide the first three months' treatment free of charge."
Health trusts launch 'sinister' bid to reduce funding for more than 100 life-saving drugs - Daily Mail 19th October 2009
"Health trusts are trying to reduce the number of life-saving drugs pioneered on the NHS, it was claimed yesterday.
A number have joined a lobby group suspected of seeking to influence the type of treatments endorsed by rationing body NICE. "
Denial of life-changing arthritis drug angers patients - Carlisle News & Star 5th October 2009
"A new drug that has changed the lives of rheumatoid arthritis sufferers from Cumbria and the north east has failed to secure the backing it needs to become available on the NHS."
Prescription guidelines deprive women of osteoporosis drugs, doctors say - The Times 8th September 2009
Women with osteoporosis are missing out on the best drugs for managing their condition because strict prescribing rules are distorting medical priorities, senior doctors said yesterday.
The availability of a cheap, generic preventive treatment for the bone-thinning disorder is “stifling” the adoption of newer, more expensive drugs that are more appropriate for many patients and promoting bad medical practice, the British Science Festival in Guildford was told.
Row over access to bone therapies - BBC Health News 8th September 2009
Thousands of women in England and Wales could suffer broken bones each year because of a lack of treatment, according to a leading physician.
Professor David Reid, from University of Aberdeen, said postmenopausal women may find they they are denied access to effective osteoporosis drugs.
Restrictions on prescription of osteoporosis drugs 'defy belief', says leading doctor - Daily Mail 8th September 2009
Thousands of women are being denied better osteoporosis drugs because of unnecessarily restrictive Government guidelines, a doctor said last night.
Professor David Reid, an expert on brittle bones, said the rules are so stringent that GPs are often prevented from giving alternative treatments to those suffering side-effects from their pills.
Kidney cancer patients fail to win appeal for expensive drugs on the NHS - The Times 26th August 2009
Hundreds of patients with kidney cancer will continue to be denied expensive drugs which could prolong their lives, despite an appeal by patients’ groups.
The National Institute for Health and Clinical Excellence (NICE) has declined to recommend bevacizumab (Avastin), sorafenib (Nexavar) and temsirolimus (Torisel) as first-line treatment options for advanced kidney cancer or cancer that has spread about the body.
Sutent for kidney cancer approved on NHS but other drugs turned down - Daily Telegraph 26th August 2009
Kidney cancer drug Sutent has been approved for use on the NHS after previously being denied, but three others have been turned down by the medicines rationing body, Nice, it was announced.
Healthcare trusts 'not paying for Nice approved drugs' - The Telegraph 20th August 2009
Four in 10 local healthcare trusts are not funding medications which have been approved by the Government’s drugs rationing body, a new survey shows.
Doctors: Government is wrong over cervical screening - The Times 2nd July 2009
The Government is wrong to refuse cervical cancer screening to those under 25, the British Medical Association said today.\n\nDoctors voted three to one that women should be screened for cervical cancer from the age of 20 a week after the Department of Health refused to lower the starting age.
NHS restrictions prompt fertility tourism boom - The Guardian June 29th 2009
Stringent NHS criteria for treatment force hundreds of women over the age of 40 to travel to clinics abroad, the first Europe-wide study of fertility tourism reveals
Women over 40 fuel boom in European 'IVF tourism' - The Independent 30th June 2009
Older British women seeking fertility treatment are having to travel to Europe because they are finding it difficult to get IVF help at home, a study has found.
Hundreds of women from the UK could be going to countries such as Spain, Slovenia and the Czech Republic where it is easier to gain access to IVF treatment, scientists discovered.
'Thousands of Britons' travel abroad for IVF, research finds - The Times 30th June 2009
Hundreds of British couples are travelling abroad for IVF treatment every month, says the first study to evaluate the extent of “fertility tourism” around Europe.
Restricted access to fertility treatment on the NHS, the high cost of private therapy at domestic clinics and a serious shortage of donated eggs are driving couples to visit overseas clinics for help in starting a family.
Hundreds of women risk health by 'fertility tourism' - The Telegraph 29th June 2009
Hundreds of older women every month could be putting their health at risk by travelling abroad for fertility treatment they cannot get in Britain, a new study suggests.
Older British women head abroad for IVF - The Telegraph 29th June 2009
Hundreds of older women denied the chance of motherhood in the UK are heading abroad each month for IVF treatment they cannot get at home.
Selected Tags
Related Tags
Health (103)- News (103)
- UHN (97)
- NHS (68)
- Financial Management (67)
- Ethics (63)
- Drug Therapy (56)
- Health Service Economics (49)
- Cost-Effectiveness (48)
- Evidence Based Practice (47)
- Private Sector (36)
- Cancer (26)
- Daily (24)
- Telegraph (24)
- Daily Mail (19)
- The Guardian (18)
- Health Economics (16)
- BBC Health News (15)
- The Times (10)
Sponsored Links
Top Contributors
Groups interested in Rationing
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo